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Interventional Endoscopic Ultrasonography: Present and Future
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Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
The technical advances in endoscopic ultrasonograpy (EUS) and accessories have enabled performing EUS-guided intervention in the 
pancreas and biliary tract. Many research centers have been performing or investigating EUS-guided drainage, EUS-guided celiac plexus 
neurolysis and block, EUS-guided anastomosis that includes choledocho-enterostomy and choledocho-gastrostomy, EUS-guided abla-
tion and injection therapy mainly for pancreatic neoplasm, EUS-guided photodynamic therapy and EUS-guided brachytherapy. Some 
of these are currently clinical applications and others are under investigations in clinical studies or animal models. Further detailed ran-
domized controlled clinical trials and the development of materials will bring us into a new era of therapeutic EUS.
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INTRODUCTION
Endoscopic ultrasonography (EUS) was developed to ob-
serve abdominal organs with a sonic probe located in the 
nearby gastrointestinal tract. With improvements of sono-
graphic resolution, application of Doppler imaging and the 
technical progress of endosonograhic accessories, EUS-guid-
ed tissue samplings have been conducted more frequently in 
various clinical situations. 
Linear-array therapeutic probes with large working chan-
nels have recently been developed. These technical advances 
enable us to perform EUS-guided intervention in the pancre-
as and for biliary tract disease in various clinical situations 
and to investigate new procedures mainly regarding the local 
control of pancreatic tumors. Moreover, new innovative tech-
niques are under investigation in animal models. In this re-
view, we focus on interventional EUS mainly for diseases of 
the pancreas and biliary tract.
EUS-GUIDED PSEUDOCYST DRAINAGE
Symptomatic and complicated pancreatic pseudocyst can 
be drained radiologically, surgically or endoscopically by way 
of gastrocystostomy or duodenocystostomy. In the appropri-
ate setting, EUS-guided drainage of a pancreatic fluid collec-
tion can be considered as the treatment of choice to treat pan-
creatic pseudocysts. A large-channel echoendoscope allows 
this to be accomplished as a single stage procedure, and so 
this avoids the need for other therapeutic procedures. It was 
reported to have a higher success rate and lower morbidity in 
several comparative studies.
1-5 
Compared to conventional endoscopic drainage, EUS sc-
anning determines the optimal puncture site by identifying 
the intervening blood vessels and the shortest needle path. 
This merit allows us to perform drainage even in cases with-
out bulging in the gut lumen. After puncture of this site, the 
technique is almost the same as conventional endoscopic 
drainage (Fig. 1). Contrast medium may be injected into the 
cyst and then a guide wire is positioned. A needle knife, a 
bougie and a dilatation balloon are introduced through the 
working channel and they are used to carry out dilatation of 
the EUS-guided transgastric or transduodenal puncture of 
the cyst. 
Below the guidewire, a nasocystic drain or stent is placed 
within the cyst to establish complete drainage of the pancre-
atic pseudocyst or abscess. A 7 Fr plastic stent is commonly 
inserted due to the size of the working channel of the echo-
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endoscope. For efficient drainage, multiple stentings com-
bined with nasocystic drainage are used. Full-covered self-
expandable metal stent insertion is currently under study to 
obtain a larger drainage route.
EUS-GUIDED CELIAC PLEXUS  
NEUROLYSIS AND BLOCK
Celiac plexus neurolysis (CPN) is the injection of absolute 
alcohol for destroying the sympathetic plexus near the celiac 
axis to relieve abdominal pain, and this is mainly done in 
pancreatic cancer patients. Celiac plexus block (CPB) is the 
injection of steroids to inhibit the pain pathway mainly in 
patients with chronic pancreatitis. In both procedures, bupi-
vacaine is usually added to relieve initial pain.
EUS-guided CPN can be done via the anterior approach, 
so it can avoid serious complications brought about by the 
posterior approach such as parasthesia, paraplegia and pneu-
mothorax.
6 Another advantage of this technique is to visual-
ize the intervening blood vessels and sometimes the ganglia 
itself. Real time visualization by EUS enables the injection 
into the celiac space and sometimes the ganglion itself.
CPN showed alleviation of pain in 70-90% of the patients 
with pancreatic cancer.
7-9 On the other hand, CPB seemed to 
yield a marginal benefit (a 30-60% response rate) in chronic 
pancreatitis patients. A few studies showed EUS-guided CPN 
provided superior pain relief compared to CT and fluorosco-
py guided celiac plexus ablation therapy.
7-9 Further studies 
are needed for assessing the long-term efficacy of CPN and 
improving pain relief in patients with chronic pancreatitis.
EUS-GUIDED ANASTOMOSIS:  
BILIARY AND PANCREATIC DUCT
Endoscopic retrograde cholangiography (ERCP) is a palli-
ative option for relief of malignant biliary obstruction. It is 
sometimes impossible due to anatomic and technical diffi-
culties. Surgical or percutaneous biliary drainage are alterna-
tive methods, but they have higher morbidity and more dis-
comfort than an endoscopic approach. EUS-guided drainage 
of the bile duct has recently been studied.
10-19 Hepaticogas-
trostomy, choledochoduodenostomy and the rendezvous 
transpapillary approach are commonly performed according 
to the anatomic feasibility. 
The bulb of the duodenum can be recommended as a pun-
cture site for choledochoduodenostomy in the case of distal 
common bile duct obstruction because it has some merits 
(Fig. 2): a close location to the bile duct, it is away from ob-
structing tumor, there are no intervening major vessels and 
good stabilization of the echoendoscope. After a convex lin-
ear-array echoendoscope guided puncture, a needle knife, 
bougies and a balloon dilator are used to make and dilate a 
route. A plastic stent or metal stent is bridged between the di-
lated bile duct and the duodenal bulb. Hepaticogastrostomy is 
performed when the left intrahepatic duct is dilated due to 
perihilar biliary obstruction (Fig. 3). The usual puncture site 
is the high body of the stomach. The method after a puncture 
is almost same as choledochoduodenostomy. In the trans-
papillary approach, EUS-guided placement of a guide-wire 
through the papilla is performed. After withdrawing the 
EUS, an endoscopist inserts an ERCP endoscope, grasps the 
Fig. 1. Endoscopic ultrasonograpy (EUS)-guided pseudocyst drainage. After EUS-guided puncture of pseudocyst (A) and dilatation of punc-
ture site, pus was coming out from infected pseudocyst (B). Endoscopic nasobiliary drainage tube would be inserted over guide wire to irri-
gate the cyst after a pigtail plastic stent was inserted (C).
A   B C8  Clin Endosc 2011;44:6-12
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transpapillary wire with a snare or a biopsy forceps and with-
draws it through the operating channel for retrograde intro-
duction of a sphincterotome over the wire. 
Around 90% technical success rates were reported. Several 
complications such as bile peritonitis, cholangitis, cholecysti-
tis, and pneumoperitoneum were observed and most cases 
were resolved without significant morbidity. Larger studies 
and more experience are necessary to define the true risk-
benefit profile of this intervention relative to other methods 
such as percutaneous access.
EUS-guided drainage techniques are also applied to the 
pancreatic duct with almost same technical approach.
16,17,19 
These have been reported in much more limited numbers of 
patients. The success rate was a little lower and the complica-
tion rate was higher than EUS-guided biliary drainage. It re-
mains technically challenging for the aspect of the difficult 
puncture of the pancreatic duct and stabilization of the endo-
scope. 
To increase the success rate and decrease the complication 
rate, the development of EUS-specific accessories is needed, 
and particularly dedicated stent systems that reduce the po-
tential for bile leak. The forward-viewing linear echoendo-
scope, which is currently only available as a prototype, may 
also help to improve the technical feasibility.
20
EUS-GUIDED CYST ABLATION
Cyst ablation with ethanol and with or without chemother-
apeutic agents showed promising results in some studies.
21-25 
They showed effective decrease or disappearance of cysts af-
ter ablation therapy on the radiological evaluation. After 3 
months or 12 months, the complete radiological eradication 
rates were 33% to 79% with minimal complications. Multiple 
endoscopic sessions might increase the rate of image-defined 
cyst resolution.
23 However, the long-term outcomes and the 
effect of preventing malignancy in mucinous cystic lesions 
have not yet been answered. Moreover, the patients who re-
ceived ablation therapies and who showed complete eradia-
tion seemed to have no need of any interventions.
23 Only ob-
servation of cysts could be enough for them. It is prudent that 
Fig. 2. Choledochoduodenostomy. Due to duodenal partial obstruction, a transpapillary metal stent insertion was impossible. After endoscopic 
ultrasonograpy-guided puncture of dilated common bile duct (CBD) (A), fully covered metal stent was inserted from duodenal bulb to distal 
CBD (B).
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the generalized clinical application of ethanol ablation is de-
ferred until well-organized clinical trials show real benefits to 
alter the natural history of pancreatic cysts.
26
EUS-GUIDED ABLATION THERAPY  
FOR SOLID PANCREATIC TUMOR
Some recent studies have shown the feasibility of radiofre-
quency (RF) ablation in pancreatic cancer in an open, percu-
taneous or laparoscopic setting.
27,28 However, RF ablation in 
the pancreas could be dangerous without cooling the adja-
cent tissue and real-time visualization of the ablation.
28-32 On 
comparing techniques, EUS-guided ablation has some theo-
retical advantages such as it is less invasive than the surgical 
approach and more selective than the percutaneous approach. 
However it is still under experimentation in animal mod-
els.
33-35 In animal models, the desirable ablation effect can be 
achieved by adjusting the time and energy delivered into por-
cine pancreas, but the complications such as pancreatitis or 
adhesion of the surrounding viscera have not been adequately 
evaluated to apply this technique to clinical fields. A more ex-
act delineation of a lesion in 3D configuration and delicate 
adjustment of the ablation area may be helpful to improve the 
safety.
Fig. 3. Hepaticogastrostomy. Jaundice hadn’t resolved after percutaneous and endoscopic drainage. Endoscopic ultrasonograpy-guided punc-
ture of a dilated left intrahepatic duct (A) and placement of metal stent (B) was performed.
A   B
Table 1. Endoscopic Ultrasonograpy-guided Injection Therapy
Material  Year  Comment
Cytoimplant
39 (Mixed lymphocyte culture)  2000 Human  PR in 2/8 patients, only one study
ONYX-015
40 (An E1B-55kD gene-deleted 
  replication-selective adenovirus)
2003 Human  PR: 2/21 patients with gemcitabine, 2 sepsis and 
2 duodenal perforation unrelated with ONYX-015
TNFerade
41-43 
    (Replication-deficient adenoviral vector with TNF-α     
   gene and a radiation-inducible promoter Egr-1)
2006 Human Combination with radiation showed dose-related  
responses in 50 patients (available only in abstract form,  
no control). Phase 2/3 study is underway.
OncoGel
44,45 (Continuous releasing paclitaxel 
  containing gel) 
2007 Swine  Safe in 8 normal pigs
Dendritic cell therapy
46,47 2009 Human  Intra-tumoral injection combined with gemcitabine,  
PR in 1/5 patients
LC beads
48 
    (Continuous releasing irinotecan loaded  
   microspheres) 
2011 Swine  Safe in 12 normal pigs10  Clin Endosc 2011;44:6-12
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Neuroendocrine tumor behaves more indolently than pan-
creatic cancer. Even in the case of metastasis, local debulking 
surgery and/or metastasectomy increases the survival of pa-
tients. Local ablation therapy with EUS-guided probe can 
theoretically be done. However, until now there were only a 
few anecdotal cases of EUS-guided ablation of neuroendo-
crine tumor. EUS-guided alcohol ablation of an insulinoma
36 
and the hepatic metastasis of insulinoma treated with percu-
taneous radio-frequency ablation
37 were reported. EUS-guid-
ed ablation might be applied to high-risk patients. 
EUS-GUIDED INJECTION THERAPY
Advanced pancreatic cancer has a dismal prognosis with 
the median survival being 3-4 months. Until now, no therapy 
has been proven to increase survival of these patients. There-
fore, the main aim of therapy is to improve the quality of life. 
Several investigational studies were conducted using EUS-
guided injection of various therapeutic agents, including var-
ious onco-viruses,
38 chemotherapeutics and immune cells. 
After animal studies with swine pancreas, some of them were 
applied to patients. Unfortunately, no agent has currently 
shown an efficient tumor killing effect (Table 1).
The EUS-guided approach to pancreatic cancer from the 
stomach and duodenum is a potentially minimal invasive op-
tion for locally advanced cases, but the injected agents have 
not been so effective in patients with advanced pancreatic 
cancer.
EUS-GUIDED PHOTODYNAMIC  
THERAPY
Following the infusion of photosensitizing drug, target tis-
sue necrosis can be induced by exposure to light of a proper 
wavelength. EUS-guided fine-needle aspiration technique 
can be used for delivery of a light source to pancreatic cancer. 
The feasibility of this therapy was tested in a healthy swine 
model.
39,40 There were no serious complications and there was 
proper tissue necrosis. Further studies that will consider the 
cost-effectiveness and biology of pancreatic cancer are needed 
for this therapy.
EUS-GUIDED FIDUCIAL PLACEMENT
A fiduciary marker or fiducial is an object used as a point of 
reference in external beam radiation therapy. Only gold fidu-
cials are available to facilitate stereotactic body radiotherapy 
(SBRT) for the treatment of locally advanced pancreatic can-
cer. Placement of gold fiducials in the lesions is performed 
with EUS-guided delivery through a 19-guage needle,
41-44 
which enables a high-dose therapeutic beam of radiation to 
reach the tumor. The technique to push fiducials to go 
through the curved pathway is a technical challenge. The sty-
let-push method or the sterile water-push method is used.
44 
The successful placement and SBRT were done in around 
90% of patients.
43,44 The fiducials migrated in less than 5% 
without complication. To define their clinical usefulness, fidu-
cial placement should be compared with conventional radia-
tion therapy in prospective randomized blinded trials.
EUS-GUIDED BRACHYTHERAPY
Intraoperative interstitial brachytherapy has showed some 
beneficial effects for the local control of malignant pancreatic 
tumors. During operation, radioactive seeds placed in the 
pancreatic tumors emit steady gamma rays that lead to local 
ablation. EUS is used to place radioactive materials into the 
pancreas without laparotomy. Iodine-125 radioactive seeds 
were inserted through a 19-guage needle.
45,46 In a pilot study, 
a partial response of unresectable pancreatic cancer was ob-
served in 26.7% (4/15 patients) with limited improvement of 
pain. Only minor complications were reported in this study 
and in some porcine models.
47 Complications such as fistula 
formation, gastrointestinal bleeding, ascending cholangitis 
and intrahepatic cyst formation were reported in operative 
settings.
48 Considering the nature of pancreatic cancer and 
risk/benefits of brachytherapy, the precise role of this modali-
ty should be carefully investigated.
CONCLUSIONS
EUS-guided therapy is a new frontier for endoscopists. 
EUS-guided pseudocyst drainage and celiac plexus neuroly-
sis and block can be recommended as a standard treatment if 
they are indicated. The others are under investigation and 
some of them showed promising results. Further progress of 
technology will make interventional EUS more useful for 
treating pancreatico-biliary diseases and well-designed clini-
cal trials will clarify the role of investigational EUS-guided 
therapies. 
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